Skip to main content
Toggle navigation
Search
Home
Back
Tweet
Poy Theprungsirikul, MD
Clinical Fellow
Yale School of Medicine
Poster(s):
P-088: Evaluating T-cell fitness pre B-cell maturation antigen (BCMA)-targeted T-cell redirection therapies (TRT) as a predictive marker for efficacy/toxicity in relapsed/refractory multiple myeloma (RRMM)
Wednesday, September 25, 2024